clinical trial · NCT00834418
Leflunomide 20 mg Tablets Under Fasting Conditions
Teva Pharmaceuticals USA·phase1·completed·n = 84
HealthyLeflunomide 20 mg TabletsARAVA™ 20 mg Tablets
brief summary
This study will compare the relative bioavailability (rate and extent of absorption) of 20 mg Leflunomide Tablets by TEVA Pharmaceuticals Industries, Ltd. with that of 20 mg ARAVA™ Tablets by Aventis Pharmaceuticals, Inc. following a single oral dose (1 x 20 mg tablet) in healthy adult subjects under fasting conditions.
started
Jun 1, 2002
primary completion
Jul 1, 2002
completion
Jul 1, 2002
last updated
Aug 20, 2024
detailed description
Criteria for Evaluation: FDA Bioequivalence Criteria
Statistical Methods: FDA bioequivalence statistical methods
official title
A Relative Bioavailability Study of 20 mg Leflunomide Tablets Under Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol